Statistics for A prospective, multicentre study to investigate the efficacy,
Total visits
| views | |
|---|---|
| A prospective, multicentre study to investigate the efficacy, | 376 |
Total visits per month
| views | |
|---|---|
| January 2025 | 0 |
| February 2025 | 0 |
| March 2025 | 0 |
| April 2025 | 0 |
| May 2025 | 0 |
| June 2025 | 0 |
| July 2025 | 0 |
File Visits
| views | |
|---|---|
| A prospective, multicentre study to investigate the efficacy, safety and tolerability of octreotide LAR® (long-acting repeatable octreotide) in the primary therapy of patients with acromegaly.pdf(legacy) | 453 |
| A prospective, multicentre study to investigate the efficacy, safety and tolerability of octreotide LAR® (long-acting repeatable octreotide) in the primary therapy of patients with acromegaly.pdf | 10 |
Top country views
| views | |
|---|---|
| China | 136 |
| United States | 133 |
| Russia | 21 |
| Germany | 16 |
| Portugal | 16 |
| France | 9 |
| Canada | 6 |
| United Kingdom | 5 |
| Italy | 5 |
| Poland | 4 |
| Netherlands | 3 |
| Spain | 2 |
| Mexico | 2 |
| Turkey | 2 |
| Brazil | 1 |
| Denmark | 1 |
| Greece | 1 |
| Hong Kong SAR China | 1 |
| Indonesia | 1 |
| India | 1 |
| Iran | 1 |
| Japan | 1 |
| Singapore | 1 |
| Vietnam | 1 |